Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
Signed-off-by: MtF.wiki Bot <bot@mtf.wiki>
- Loading branch information
1 parent
5abca62
commit 1f4b944
Showing
2 changed files
with
36 additions
and
0 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,34 @@ | ||
# 药品网络销售禁止清单(征求意见稿)(第一版)(2022 年 11 月制定) | ||
|
||
来源:<https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20221103155815144.html> | ||
|
||
存档:<https://web.archive.org/web/20221116163057/https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20221103155815144.html> | ||
|
||
--- | ||
|
||
索引号:FGWJ-2022-245 | ||
|
||
## 一、政策法规明确禁止销售的药品 | ||
|
||
疫苗、血液制品、麻醉药品、精神药品、医疗用毒性药品、放射性药品、药品类易制毒化学品、 | ||
|
||
医疗机构制剂、中药配方颗粒。 | ||
|
||
## 二、其他禁止通过网络零售的药品 | ||
|
||
1. 注射剂(降糖类药物除外)。 | ||
|
||
1. 含麻黄碱类复方制剂(不包括含麻黄的中成药,下同)、 | ||
《关于进一步加强含可待因复方口服溶液、复方甘草片和复方地芬诺酯片购销管理的通知》(食药监办药化监〔2013〕33 号) | ||
《食品药品监管总局办公厅关于进一步加强含麻醉药品和曲马多口服复方制剂购销管理的通知》(食药监办药化监〔2014〕111 号) | ||
所列的品种以及右美沙芬。 | ||
|
||
1. 《兴奋剂目录》所列的蛋白同化制剂和肽类激素(胰岛素除外)。 | ||
|
||
1. 用药风险较高的品种:地高辛、丙吡胺、奎尼丁、哌唑嗪、普鲁卡因胺、普罗帕酮、胺碘酮、奎宁、氨茶碱、胆茶碱、异丙肾上腺素; | ||
|
||
苯妥英钠、卡马西平、拉莫三嗪、水合氯醛、达比加群酯、华法林、替格瑞洛、西洛他唑、扑米酮、碳酸锂、异氟烷、七氟烷、恩氟烷、地氟烷、秋水仙碱; | ||
|
||
米非司酮、复方米非司酮、环丙孕酮、卡前列甲酯、雌二醇、米索前列醇、地诺前列酮; | ||
|
||
法罗培南、夫西地酸、伏立康唑、利奈唑胺、奈诺沙星、泊沙康唑、头孢地尼、伊曲康唑、左奥硝唑、头孢泊肟酯。 |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters